Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilars, Generic Programs Leave Little Room For Other New FDA Drug Initiatives In FY ‘13

Feb 20 2012

• By Cathy Dombrowski

Related Content

Speedy Vaccine Production Among Goals Of FDA's Budget Proposal For Countermeasures

Feb 21 2011

FDA’s Generic Drug Office Goes On Diet Before Swallowing User Fees

Nov 28 2011

GOP Drug Shortage Strategy Pushes FDA Reform, Reimbursement Over Notification

Feb 13 2012

FDA Biosimilars Guidances Address Immunogenicity Studies, European Bridge Data, Analytics

Feb 13 2012

FDA May Be Catching Up With FDAAA Workload, Latest Performance Data Suggests

Oct 25 2010

FDA’s Price Tag For Foreign Facility Inspections Tops $225 Million

May 05 2008

User Fee Triggers Require Care In Unfriendly Budget Environment, Ventimiglia Says

Dec 05 2011

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window